Literature DB >> 15179522

[Nucleoside induced hepatopathy in HIV patients. Diagnostic value of liver biopsy assessment].

S Haas1, J K Rockstroh, U Spengler, H-P Fischer.   

Abstract

Hepatic steatosis together with lactic acidosis is a life threatening side effect in HIV infected patients receiving highly active antiretroviral therapy (HAART). We describe 5 patients developing hepatic drug toxicity during longterm treatment with nucleoside reverse transcriptase inhibitors. The main clinical symptoms included abdominal pain, fever, and neurological disorders. Serum lactate levels were elevated leading to severe metabolic acidosis in 3 cases. Liver biopsies revealed extensive macro- and microvesicular steatosis. Mitochondrial alterations were detected by electronmicroscopy. Microvesicular steatosis was seen in one case with elevated liver enzymes, but normal serum lactate levels, and was most extensive in a patient with a severe lactic acidotic coma. We conclude that detection of microvesicular steatosis and mitochondrial alterations in liver biopsies may help to identify the development of a nucleoside induced hepatopathy before the onset of severe lactic acidosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15179522     DOI: 10.1007/s00292-004-0694-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  20 in total

1.  Hepatic mitochondrial toxicity from nucleoside analog therapy.

Authors:  H I Finkle
Journal:  Arch Pathol Lab Med       Date:  1999-03       Impact factor: 5.534

2.  Steatosis-lactic acidosis syndrome associated with stavudine and lamivudine therapy.

Authors:  S Johri; S Alkhuja; G Siviglia; A Soni
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

3.  Antiretroviral-induced hepatic steatosis and lactic acidosis: case report and review of the literature.

Authors:  S Ellozy; R Massen; L Chao; C M Divino
Journal:  Am Surg       Date:  2001-07       Impact factor: 0.688

Review 4.  Antiretroviral drug toxicity -- a challenge for the hepatologist?

Authors:  Ulrich Spengler; Mathias Lichterfeld; Jürgen Kurt Rockstroh
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

5.  [Fatty liver and increased serum lactate in a woman with HIV].

Authors:  M Lichterfeld; H P Fischer; U Spengler; J K Rockstroh
Journal:  Dtsch Med Wochenschr       Date:  2003-01-17       Impact factor: 0.628

6.  Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases.

Authors:  M E Coghlan; J P Sommadossi; N C Jhala; W J Many; M S Saag; V A Johnson
Journal:  Clin Infect Dis       Date:  2001-10-24       Impact factor: 9.079

Review 7.  Mitochondria in steatohepatitis.

Authors:  D Pessayre; A Berson; B Fromenty; A Mansouri
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

Review 8.  Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

Authors:  T N Kakuda
Journal:  Clin Ther       Date:  2000-06       Impact factor: 3.393

9.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 10.  Disorders of the mitochondria.

Authors:  W R Treem; R J Sokol
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.